TRIPALMITIN

TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.

Cross Reference

Introduction

To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with TRIPALMITIN?

TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with TRIPALMITIN

MeSH term MeSH ID Detail
Leishmaniasis, Visceral D007898 13 associated lipids
Respiratory Distress Syndrome, Newborn D012127 5 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
HIV-Associated Lipodystrophy Syndrome D039682 3 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with TRIPALMITIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with TRIPALMITIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with TRIPALMITIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with TRIPALMITIN?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with TRIPALMITIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with TRIPALMITIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with TRIPALMITIN

Download all related citations
Per page 10 20 50 100 | Total 272
Authors Title Published Journal PubMed Link
Hart SM et al. Emulsion droplet crystallinity attenuates early in vitro digestive lipolysis and beta-carotene bioaccessibility. 2018 Food Chem pmid:29699655
Shiota M et al. Mass spectrometric imaging of localization of fat molecules in water-in-oil emulsions containing semi-solid fat. 2018 Food Chem pmid:29287345
Bayard M et al. Free fatty acids and their esters modulate isothermal crystallization of anhydrous milk fat. 2017 Food Chem pmid:27719901
Pawlik A et al. Food-grade Pickering emulsions stabilised with solid lipid particles. 2016 Food Funct pmid:27198879
Ciafardini G et al. Lipase production by yeasts from extra virgin olive oil. 2006 Food Microbiol. pmid:16942987
Lichtenberger LM et al. Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. 1990 Gastroenterology pmid:2365185
Newcomer AD et al. Triolein breath test: a sensitive and specific test for fat malabsorption. 1979 Gastroenterology pmid:758149
Aihara Y et al. Construction of a taste-blind medaka fish and quantitative assay of its preference-aversion behavior. 2008 Genes Brain Behav. pmid:18700838
Lugea A et al. Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins. 2000 Gut pmid:10716681
Fujimoto T et al. Lipid droplets: a classic organelle with new outfits. 2008 Histochem. Cell Biol. pmid:18546013
Holmes AK et al. Ultrasonic scattering in chocolate and model systems containing sucrose, tripalmitin and olive oil. 2007 IEEE Trans Ultrason Ferroelectr Freq Control pmid:18051170
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Solanki GK et al. Polaron hopping in some biomolecular solids and their charge transfer complexes. 2008 Indian J. Biochem. Biophys. pmid:19239130
Fulda S et al. Cellular stress responses: cell survival and cell death. 2010 Int J Cell Biol pmid:20182529
Qi C et al. Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis. 2011 Int J Mol Sci pmid:21845078
Zarevúcka M and Wimmer Z Plant products for pharmacology: application of enzymes in their transformations. 2008 Int J Mol Sci pmid:19330086
Kashanian S et al. New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell. 2011 Int J Nanomedicine pmid:22114489
Mansour HM et al. Nanomedicine in pulmonary delivery. 2009 Int J Nanomedicine pmid:20054434
Uner M and Yener G Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. 2007 Int J Nanomedicine pmid:18019829
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Appel B et al. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. 2006 Int J Pharm pmid:16569486
Elkharraz K et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. 2006 Int J Pharm pmid:16490330
Koennings S et al. In vitro investigation of lipid implants as a controlled release system for interleukin-18. 2006 Int J Pharm pmid:16513302
Guse C et al. Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids. 2006 Int J Pharm pmid:16517106
Tsai MJ et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. 2012 Int J Pharm pmid:22193056
Garcia-Fuentes M et al. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. 2005 Int J Pharm pmid:15885464
Illing A and Unruh T Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles. 2004 Int J Pharm pmid:15454303
Lopes DG et al. Microphase separation in solid lipid dosage forms as the cause of drug release instability. 2017 Int J Pharm pmid:28007547
Becker K et al. Advanced stable lipid-based formulations for a patient-centric product design. 2016 Int J Pharm pmid:26621689
Bondì ML et al. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. 2015 Int J Pharm pmid:26211902
Witzleb R et al. Dissolution of solid lipid extrudates in biorelevant media. 2012 Int J Pharm pmid:22044538
Kumar VV et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. 2007 Int J Pharm pmid:17161566
Fadda P et al. Solid lipid nanoparticle preparation by a warm microemulsion based process: influence of microemulsion microstructure. 2013 Int J Pharm pmid:23422277
Reithmeier H et al. Development and characterization of lipid microparticles as a drug carrier for somatostatin. 2001 Int J Pharm pmid:11337157
Olbrich C et al. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity. 2002 Int J Pharm pmid:11955810
Ahlin P et al. Influence of spin probe structure on its distribution in SLN dispersions. 2000 Int J Pharm pmid:10699727
Schwendner SW et al. Potential organ or tumor imaging agents. 32. A triglyceride ester of p-iodophenyl pentadecanoic acid as a potential hepatic imaging agent. 1992 Int J Rad Appl Instrum B pmid:1522018
Jawahar N et al. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. 2018 Int. J. Biol. Macromol. pmid:29402457
Schneider M et al. A new ultrasound contrast agent based on biodegradable polymeric microballoons. 1991 Invest Radiol pmid:1808125
Potta SG et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. 2010 J Biomed Nanotechnol pmid:21361127
Schmiele M et al. Formation of liquid crystalline phases in aqueous suspensions of platelet-like tripalmitin nanoparticles. 2014 J Chem Phys pmid:24908039
Hazotte A et al. High-temperature micro liquid chromatography for lipid molecular species analysis with evaporative light scattering detection. 2007 J Chromatogr A pmid:17161844
Gaudin K et al. Adaptation of an evaporative light-scattering detector to micro and capillary liquid chromatography and response assessment. 2004 J Chromatogr A pmid:15532554
Holčapek M et al. Regioisomeric analysis of triacylglycerols using silver-ion liquid chromatography-atmospheric pressure chemical ionization mass spectrometry: comparison of five different mass analyzers. 2010 J Chromatogr A pmid:21075380
Müller M et al. Development of solvent systems with room temperature ionic liquids for the countercurrent chromatographic separation of very nonpolar lipid compounds. 2017 J Chromatogr A pmid:28179081
Helgason T et al. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). 2009 J Colloid Interface Sci pmid:19380149
Garcia-Fuentes M et al. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. 2005 J Colloid Interface Sci pmid:15837476
Tikka HK et al. Soiling of pure PVC studied by FTIR, optical microscopy, and AFM. 2004 J Colloid Interface Sci pmid:15082372
Windbergs M et al. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures. 2009 J Control Release pmid:19358867
Vitorino C et al. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. 2013 J Control Release pmid:23454133